Related Experiment Videos

Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock

Nirav J Mehta1, Ijaz A Khan, Vipin Gupta

  • 1Division of Cardiology, Creighton University School of Medicine, 3006 Webster Street, Omaha, NE 68131, USA.

International Journal of Cardiology
|May 26, 2004
PubMed

Insights

Elevated serum cardiac troponin I (cTnI) indicates myocardial injury in septic shock patients. High cTnI levels correlate with myocardial dysfunction and predict increased sepsis severity and mortality.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Biochemistry

Background:

  • Septic shock frequently leads to myocardial dysfunction.
  • Assessing myocardial injury in septic shock is crucial for patient outcomes.

Purpose of the Study:

  • To determine myocardial injury in septic shock using serum cardiac troponin I (cTnI).
  • To evaluate the relationship between elevated cTnI and myocardial dysfunction.
  • To assess cTnI as a predictor of outcomes in septic shock patients.

Main Methods:

  • Thirty-seven septic shock patients were enrolled.
  • Serum cTnI levels were measured at baseline, 24, and 48 hours.
  • Echocardiography, ECG, and hemodynamic assessments were performed.

Main Results:

  • 43% of patients exhibited elevated cTnI.
  • Elevated cTnI correlated with increased need for vasopressors, higher APACHE II scores, and wall motion abnormalities.
  • Higher cTnI levels were associated with lower ejection fraction and increased mortality.

Conclusions:

  • Serum cTnI effectively identifies myocardial injury in septic shock.
  • Elevated cTnI correlates with myocardial dysfunction and predicts worse outcomes.
  • Close monitoring of septic shock patients with elevated cTnI is recommended.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...